Results 21 to 30 of about 368,892 (303)
A novel and effective cancer immunotherapy mouse model using antigen-specific B cells selected in vitro. [PDF]
PLoS ONE, 2014 Immunotherapies such as adoptive transfer of T cells or natural killer cells, or monoclonal antibody (MoAb) treatment have recently been recognized as effective means to treat cancer patients.
Tatsuya Moutai +3 more
doaj +1 more source
Tracking adoptive T cell immunotherapy using magnetic particle imaging
Nanotheranostics, 2021 Adoptive cellular therapy (ACT) is a potent strategy to boost the immune response against cancer. ACT is effective against blood cancers but faces challenges in treating solid tumors.
Angelie Rivera-Rodriguez +6 more
semanticscholar +1 more source
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Science, 2020 Stem-like T cells mediate response Adoptive cell transfer (ACT) is a type of immunotherapy that uses a patient's own T lymphocytes to recognize and attack cancer.
S. Krishna +21 more
semanticscholar +1 more source
Frontiers in Pharmacology, 2021 So far, immunotherapy has been shown to have impressive effects on different cancers in clinical trials. All those immunotherapies are generally derived from three main therapeutic approaches: immune checkpoint inhibitors, immune cell vaccination, and ...
Fanming Kong +7 more
doaj +1 more source
Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT
Сибирский онкологический журнал, 2016 A lot of research is focused on finding better treatment options for cancer. Along with radical treatment, cancer immunotherapy has proved to be useful for a growing number of cancer patients.
E. V. Abakushina +5 more
doaj +1 more source
Cancer Discovery, 2017 Lymphodepletion chemotherapy followed by infusion of CD19-targeted chimeric antigen receptor (CAR)-modified T (CAR-T) cells can be complicated by neurologic adverse events (AEs) in patients with refractory B cell malignancies.
J. Gust +23 more
semanticscholar +1 more source
LYMPHOCYTE PHENOTYPE IN PATIENTS WITH SKIN MELANOMA AFTER IMMUNOTHERAPY OF ACTIVATED LYMPHOCYTES
Медицинская иммунология, 2015 The major medical problem in the treatment of skin melanoma is improvement methods of treatment, increasing their effectiveness and safety. In this study, adoptive immunotherapy, using lymphocytes activated in vitro, was performed in 15 patients with ...
E. V. Abakushina +5 more
doaj +1 more source
Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review.
PLoS ONE, 2012 PurposeThe effectiveness of immunotherapy for postoperative hepatocellular carcinoma patients is still controversial. To address this issue, we did a systemic review of the literatures and analyzed the data with emphasis on the recurrence and survival ...
Feng Xie +8 more
doaj +1 more source
PLoS ONE, 2016 BackgroundAdoptive immunotherapy (AI) has been applied in the treatment of non-small-cell lung cancer (NSCLC) patients, but the value of postoperative AI has been inconclusive largely as a result of the small number of patients included in each study. We
Yuan Zeng +7 more
doaj +1 more source
TCR Gene Therapy: Challenges, Opportunities, and Future Directions
Cells, 2020 Adoptive immunotherapy with gene-engineered T cells has provided new treatment options for cancer patients [...]
Hans J. Stauss, Maxine G. B. Tran
doaj +1 more source